WO1997012969A3 - Proteine apparentee a fmr1 - Google Patents

Proteine apparentee a fmr1 Download PDF

Info

Publication number
WO1997012969A3
WO1997012969A3 PCT/DE1996/001787 DE9601787W WO9712969A3 WO 1997012969 A3 WO1997012969 A3 WO 1997012969A3 DE 9601787 W DE9601787 W DE 9601787W WO 9712969 A3 WO9712969 A3 WO 9712969A3
Authority
WO
WIPO (PCT)
Prior art keywords
fmr1
protein
related protein
dna
codes
Prior art date
Application number
PCT/DE1996/001787
Other languages
German (de)
English (en)
Other versions
WO1997012969A2 (fr
Inventor
Annemarie Poustka
Johannes Coy
Original Assignee
Deutsches Krebsforsch
Annemarie Poustka
Johannes Coy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Annemarie Poustka, Johannes Coy filed Critical Deutsches Krebsforsch
Priority to JP9513875A priority Critical patent/JP2000500962A/ja
Priority to EP96945134A priority patent/EP0851923A2/fr
Publication of WO1997012969A2 publication Critical patent/WO1997012969A2/fr
Publication of WO1997012969A3 publication Critical patent/WO1997012969A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne une protéine apparentée à FMR1, un ADN de codage de cette protéine, un procédé de préparation de cette protéine, l'utilisation de l'ADN et de la protéine et les anticorps dirigés contre cette protéine.
PCT/DE1996/001787 1995-09-19 1996-09-19 Proteine apparentee a fmr1 WO1997012969A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP9513875A JP2000500962A (ja) 1995-09-19 1996-09-19 Ｆｍｒ１関連蛋白質
EP96945134A EP0851923A2 (fr) 1995-09-19 1996-09-19 Proteine apparentee a fmr1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1995134763 DE19534763C1 (de) 1995-09-19 1995-09-19 FMR1-verwandtes Protein
DE19534763.3 1995-09-19

Publications (2)

Publication Number Publication Date
WO1997012969A2 WO1997012969A2 (fr) 1997-04-10
WO1997012969A3 true WO1997012969A3 (fr) 1997-07-17

Family

ID=7772586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/001787 WO1997012969A2 (fr) 1995-09-19 1996-09-19 Proteine apparentee a fmr1

Country Status (4)

Country Link
EP (1) EP0851923A2 (fr)
JP (1) JP2000500962A (fr)
DE (1) DE19534763C1 (fr)
WO (1) WO1997012969A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000072201A (ko) * 2000-08-17 2000-12-05 김희태 여러 종류의 디엔에이 프로브들을 사용한 취약-엑스증후군의 진단 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038467A1 (fr) * 1995-05-31 1996-12-05 The Trustees Of The University Of Pennsylvania Proteines liees a l'x fragile, leurs compositions et procedes de production et d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038467A1 (fr) * 1995-05-31 1996-12-05 The Trustees Of The University Of Pennsylvania Proteines liees a l'x fragile, leurs compositions et procedes de production et d'utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SIOMI, M.C. ET AL.: "FRX1, an autosomal homolog of the fragile X mental retardation gene", EMBO JOURNAL, vol. 14, no. 11, 1 June 1995 (1995-06-01), EYNSHAM, OXFORD GB, pages 2401 - 2408, XP000673943 *
ZHANG, Y. ET AL.: "The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2", EMBO JOURNAL, vol. 14, no. 21, 1 November 1995 (1995-11-01), EYNSHAM, OXFORD GB, pages 5358 - 5366, XP000673942 *

Also Published As

Publication number Publication date
WO1997012969A2 (fr) 1997-04-10
EP0851923A2 (fr) 1998-07-08
JP2000500962A (ja) 2000-02-02
DE19534763C1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
DE69534778D1 (en) Cathepsin-02-protease
AU7489596A (en) Reinforced formed part, process for its production and its use
AU5571396A (en) Process for preparing anti-obesity protein
HUP9602745A2 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
AU2455295A (en) Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
WO1996027665A3 (fr) Proteines ayant les proprietes d'un facteur silenceur exerçant une action de repression sur les neurones
EP0831098A3 (fr) Produits intermédiaires et procédé pour la préparation d'olanzapine
AU5678396A (en) Methods of preparing soluble, oligomeric proteins
HUP9600325A3 (en) Dna sequence of a. thaliana, delta-7-red protein, process for producing thereof, yeats strains transformed by this dna and use thereof
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
WO1997035015A3 (fr) Proteine apparentee a la tyrosine-phosphatase
WO1997012969A3 (fr) Proteine apparentee a fmr1
WO1997029194A3 (fr) Preparation d'acide l-ascorbique
CA2213742A1 (fr) Methode pour preparer un plasma deficient en facteur v; plasma deficient ainsi obtenu
CA2194032A1 (fr) Sequence d'adn fusionnee, proteine fusionnee exprimee par ladite sequence d'adn et methode d'expression de ladite proteine fusionnee
WO1997005253A3 (fr) Proteine apparentee a la transcetolase
ZA966661B (en) Catalyst, use thereof and preparation process.
AU6601096A (en) Dax-1 protein, methods for production and use thereof
HUP9602331A3 (en) Alkenyl-benzoyl-guanidine derivatives, pharmaceutical compns. contg. the said compds., process for preparing them and the use of the compds.
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
AU4716196A (en) Method of producing oxazolidinones, the use thereof and novel oxazolidinones
DE59611293D1 (de) Protein mit dnase-aktivität
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 513875

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996945134

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996945134

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996945134

Country of ref document: EP